Cruiser Capital Advisors LLC Has $1.05 Million Stake in Core Scientific, Inc. (NASDAQ:CORZ)

Cruiser Capital Advisors LLC raised its stake in Core Scientific, Inc. (NASDAQ:CORZ) by 15.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 74,458 shares of the company’s stock after acquiring an additional 10,000 shares during the period. Core Scientific comprises about 0.6% of Cruiser Capital Advisors LLC’s investment portfolio, making the stock its 21st largest position. Cruiser Capital Advisors LLC’s holdings in Core Scientific were worth $1,046,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently bought and sold shares of CORZ. EntryPoint Capital LLC bought a new stake in shares of Core Scientific in the 4th quarter worth about $326,000. Congress Wealth Management LLC DE bought a new stake in Core Scientific during the fourth quarter worth about $219,000. Advantage Alpha Capital Partners LP bought a new stake in Core Scientific during the fourth quarter worth about $1,884,000. Vanguard Group Inc. increased its holdings in shares of Core Scientific by 54.3% during the fourth quarter. Vanguard Group Inc. now owns 19,378,652 shares of the company’s stock worth $272,270,000 after buying an additional 6,819,406 shares in the last quarter. Finally, LPL Financial LLC raised its stake in shares of Core Scientific by 42.9% in the fourth quarter. LPL Financial LLC now owns 421,213 shares of the company’s stock valued at $5,918,000 after acquiring an additional 126,454 shares during the last quarter.

Insider Activity

In other Core Scientific news, insider Todd M. Duchene sold 129,861 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $14.24, for a total value of $1,849,220.64. Following the completion of the transaction, the insider now directly owns 2,051,649 shares of the company’s stock, valued at approximately $29,215,481.76. The trade was a 5.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Adam Taylor Sullivan sold 369,712 shares of the firm’s stock in a transaction dated Friday, January 24th. The stock was sold at an average price of $16.24, for a total value of $6,004,122.88. Following the sale, the chief executive officer now directly owns 3,758,793 shares in the company, valued at approximately $61,042,798.32. This represents a 8.96 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 748,282 shares of company stock valued at $10,978,104 in the last quarter. Company insiders own 32.00% of the company’s stock.

Core Scientific Trading Up 9.4 %

Shares of CORZ opened at $9.31 on Tuesday. The stock has a market cap of $2.74 billion, a P/E ratio of -1.72 and a beta of 6.83. Core Scientific, Inc. has a 1 year low of $2.61 and a 1 year high of $18.63. The stock’s 50-day moving average price is $11.41 and its two-hundred day moving average price is $13.18.

Core Scientific (NASDAQ:CORZ) last issued its quarterly earnings data on Wednesday, February 26th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.09. The firm had revenue of $94.93 million for the quarter, compared to analyst estimates of $97.07 million. As a group, equities analysts forecast that Core Scientific, Inc. will post 0.52 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. HC Wainwright reaffirmed a “buy” rating and set a $17.00 price target on shares of Core Scientific in a report on Tuesday, March 11th. Craig Hallum initiated coverage on Core Scientific in a research note on Tuesday, January 21st. They issued a “buy” rating and a $24.00 target price for the company. BTIG Research upped their price target on shares of Core Scientific from $19.00 to $20.00 and gave the stock a “buy” rating in a research report on Monday, December 16th. Canaccord Genuity Group restated a “buy” rating and issued a $17.00 price objective on shares of Core Scientific in a research report on Wednesday, March 12th. Finally, Keefe, Bruyette & Woods initiated coverage on shares of Core Scientific in a research report on Monday, January 27th. They set an “outperform” rating and a $22.00 target price on the stock. Fifteen investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $19.07.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.